Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Spain- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Spain3 clinical trials in La Roca del Valles, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on atherosclerotic cardiovascular disease prevention are currently underway. The research aims to evaluate innovative treatments for reducing major adverse cardiovascular events in high-risk patients.
These studies represent significant advancement in preventive cardiology and patient care strategies.
Important research is being conducted in the field of osteoarthritis, specifically targeting knee pain management. These trials evaluate novel therapeutic approaches for improving patient mobility and quality of life.
The research focuses on developing effective interventions for chronic joint pain relief.
Tell us about your condition – we search every trial in Europe and connect you with the right site.